Stejbach Mark 4
4 · Flexion Therapeutics Inc · Filed May 27, 2020
Insider Transaction Report
Form 4
Stejbach Mark
Director
Transactions
- Purchase
Common Stock
2020-05-26$9.75/sh+2,051$19,997→ 2,051 total
Holdings
- 1,580(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The shares were purchased in connection with the Issuer's public offering.